BNP Promotes Platelet Activation and Thrombosis via its Receptor NPRA: A Paradigm Shift from Biomarker to Effector

The authors investigate whether B-type natriuretic peptide (BNP) directly contributes to cardiovascular disease pathogenesis, particularly in promoting thrombosis, rather than merely serving as a biomarker. Their findings reveal that BNP enhances platelet activation and thrombus formation through its receptor NPRA, suggesting a direct role in increasing thrombotic risk in cardiovascular conditions. This research shifts the understanding of BNP from a simple biomarker to an active effector in thrombotic processes.